Insider Selling: II-VI Incorporated (IIVI) CFO Sells $45,000.00 in Stock

II-VI Incorporated (NASDAQ:IIVI) CFO Mary Jane Raymond sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $45.00, for a total transaction of $45,000.00. Following the sale, the chief financial officer now directly owns 53,415 shares in the company, valued at approximately $2,403,675. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

II-VI Incorporated (IIVI) traded down $2.80 during midday trading on Friday, hitting $41.50. 667,155 shares of the stock were exchanged, compared to its average volume of 654,451. The firm has a market cap of $2.61 billion, a P/E ratio of 25.06 and a beta of 0.02. II-VI Incorporated has a one year low of $26.70 and a one year high of $46.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.70 and a current ratio of 3.89.

II-VI (NASDAQ:IIVI) last issued its quarterly earnings results on Tuesday, October 31st. The scientific and technical instruments company reported $0.32 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.36 by ($0.04). The company had revenue of $261.50 million for the quarter, compared to analyst estimates of $255.20 million. II-VI had a return on equity of 12.25% and a net margin of 9.89%. The company’s quarterly revenue was up 18.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.35 EPS. analysts expect that II-VI Incorporated will post 1.56 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was first published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.com-unik.info/2017/11/04/insider-selling-ii-vi-incorporated-iivi-cfo-sells-45000-00-in-stock.html.

A number of analysts have weighed in on IIVI shares. BidaskClub raised shares of II-VI from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th. Craig Hallum started coverage on shares of II-VI in a research report on Monday, July 24th. They set a “buy” rating and a $50.00 target price on the stock. B. Riley lowered shares of II-VI from a “buy” rating to a “neutral” rating and raised their target price for the stock from $35.75 to $39.50 in a research report on Wednesday, July 26th. Northland Securities set a $45.00 target price on shares of II-VI and gave the stock a “buy” rating in a research report on Monday, August 7th. Finally, Benchmark Co. raised their target price on shares of II-VI from $40.00 to $44.00 and gave the stock a “buy” rating in a research report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $48.75.

Several institutional investors and hedge funds have recently made changes to their positions in IIVI. Pinebridge Investments L.P. lifted its stake in shares of II-VI by 1.9% in the 2nd quarter. Pinebridge Investments L.P. now owns 7,237 shares of the scientific and technical instruments company’s stock valued at $249,000 after acquiring an additional 137 shares during the last quarter. Piedmont Investment Advisors LLC bought a new position in shares of II-VI in the 2nd quarter valued at $407,000. Paloma Partners Management Co bought a new position in shares of II-VI in the 1st quarter valued at $417,000. SG Americas Securities LLC lifted its stake in shares of II-VI by 329.0% in the 2nd quarter. SG Americas Securities LLC now owns 15,112 shares of the scientific and technical instruments company’s stock valued at $518,000 after acquiring an additional 11,589 shares during the last quarter. Finally, OppenheimerFunds Inc. raised its position in II-VI by 22.6% during the 1st quarter. OppenheimerFunds Inc. now owns 21,405 shares of the scientific and technical instruments company’s stock worth $771,000 after purchasing an additional 3,948 shares during the last quarter. Institutional investors own 78.17% of the company’s stock.

About II-VI

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Insider Buying and Selling by Quarter for II-VI (NASDAQ:IIVI)

What are top analysts saying about II-VI Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for II-VI Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit